SE302617B - - Google Patents

Info

Publication number
SE302617B
SE302617B SE10643/62A SE1064362A SE302617B SE 302617 B SE302617 B SE 302617B SE 10643/62 A SE10643/62 A SE 10643/62A SE 1064362 A SE1064362 A SE 1064362A SE 302617 B SE302617 B SE 302617B
Authority
SE
Sweden
Application number
SE10643/62A
Inventor
F Chillemi
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Publication of SE302617B publication Critical patent/SE302617B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE10643/62A 1961-10-05 1962-10-04 SE302617B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1798361 1961-10-05
IT216162 1962-02-05

Publications (1)

Publication Number Publication Date
SE302617B true SE302617B (en) 1968-07-29

Family

ID=26325222

Family Applications (1)

Application Number Title Priority Date Filing Date
SE10643/62A SE302617B (en) 1961-10-05 1962-10-04

Country Status (7)

Country Link
CH (1) CH429754A (en)
DE (1) DE1518133B1 (en)
DK (2) DK108976C (en)
ES (1) ES281304A1 (en)
FR (1) FR2822M (en)
GB (1) GB984810A (en)
SE (1) SE302617B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
CN101663262B (en) 2006-12-01 2014-03-26 百时美施贵宝公司 N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (en) 2019-01-18 2023-01-30 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
DK104307C (en) 1966-05-02
GB984810A (en) 1965-03-03
CH429754A (en) 1967-02-15
DE1518133B1 (en) 1970-08-20
DK108976C (en) 1968-03-04
ES281304A1 (en) 1963-04-16
FR2822M (en) 1964-10-05

Similar Documents

Publication Publication Date Title
BE621916A (en)
BE616824A (en)
BE623716A (en)
BE600261A (en)
BE626278A (en)
BE619798A (en)
BE600768A (en)
BE617696A (en)
BE615499A (en)
BE612740A (en)
BE612442A (en)
BE602240A (en)
BE602153A (en)
BE602045A (en)
BE601970A (en)
BE601847A (en)
BE601846A (en)
BE601844A (en)
BE601744A (en)
BE601679A (en)
BE601532A (en)
BE601488A (en)
BE601466A (en)
BE493336A (en)
BE482264A (en)